The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...
Provepharm, Inc., of Pennsylvania, announced their nationwide voluntary recall on Friday, January 24, and the FDA followed suit the same day. The recall affects one lot of phenylephrine ...
Provepharm said it pulled lot No. 24020027 with December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/mL after getting “a customer complaint from a pharmacy after observing a ...